NCT05634863View on ClinicalTrials.gov

CONtinuous Implantable DOppler Probe Monitoring in Renal Transplantation

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Renal Artery ComplicationsRenal Vein Thrombosis
Interventions
DEVICE

Implantable Doppler probe manufactured by COOK Medical Company.

The continuous audible Doppler signals produced by the monitoring device represent the blood flowing in the renal artery. This is an indicator of graft perfusion. Cessation of audible Doppler signals is the key that may suggest hampered blood flow due to vascular complications. In the intervention group, the monitoring device will be used as an added mechanism to monitor graft perfusion.

Trial Locations (1)

PL3 4RN

University Hospitals Plymouth NHS Trust, Plymouth

All Listed Sponsors
lead

University Hospital Plymouth NHS Trust

OTHER